What Researchers Did
Researchers conducted a randomized trial with 71 patients to assess the efficacy of hyperbaric oxygen therapy (HBOT) as an adjuvant to conventional periodontal treatment.
What They Found
At the study's conclusion, the 31 patients who received hyperbaric oxygen therapy (HBOT) showed significantly better values in oral health index, sulcus bleeding index, dental mobility, and periodontal pocket depth compared to the 40 patients in the control group. This indicates that HBOT had beneficial effects on both oral and general health, with some individual symptoms diminishing or disappearing.
What This Means for Canadian Patients
Canadian patients with mild to moderate periodontal disease might benefit from hyperbaric oxygen therapy as an adjunctive treatment to conventional scaling and root planing. This could potentially lead to improved oral health outcomes and a reduction in associated symptoms.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
A limitation of this study is its relatively small sample size of 71 participants, which may limit the generalizability of the findings.